Who Can Propel Global Longevity? FIIPRIORITY

The discussion featured two prominent investors, Nisa and Josh, focusing on longevity and healthspan. Longevity shouldn't only aim to extend life but ensure those additional years are healthy and productive. Preventative medicine, early diagnosis, healthy lifestyles, and emerging technologies are pivotal. Rejuvenative medicine, such as Yamanaka factors, shows promise in reversing cellular aging. AI is significantly impacting healthcare, aiding in drug discovery and optimizing medical workflows. There's a need to balance innovation with equity in global healthcare access, ensuring novel treatments are affordable and widely distributed.